检测EML4-ALK融合基因对肺腺癌患者的临床意义

Detection of EML4—ALK fusion gene in patient with lung adenocarcinoma

目的探讨检测EML4-ALK融合基因对肺腺癌患者的临床意义。方法收集2012年7至12月手术或活检肺腺癌组织标本37例,所有标本均经病理证实为腺癌,用RT-PCR方法检测EML4-ALK融合基因的表达,设计9种探针检测EML4-ALK融合基因最常见的9种类型,并随访阳性息者的治疗结果。结果37例腺癌标本中,1例检出EML4-ALK融合基因表达阳性,并经测序法证实为1型变异,检出率2.70%。为女性患者,左上肺肿块,T_1N_0N_0,行左肺上叶肺癌根治术,术后给予克唑替尼,随访6个月无复发。结论使用RT-PCR结合测序是一种快速、简便、容易推广的EML4-ALK融合基因检测技术,可以在肺腺癌患者检测中推广使用。

Objective To detect echinoderm microtubule-associated protein-like 4 （EML4） - anaplastic lymphoma ki- nase （ALK） fusion gene in patients with non-small cell lung cancer （NSCLC）. Methods Biopsy or surgical specimens were col- lected from 37 patients with pathologically confirmed adenocarcinoma from July 2012 to Dec 2012. The expression of ELM4-ALK fusion gene was detected by RT-PCR with primers designed for 9 subtypes of the fusion gene, and the detected gene was veri- fied by sequencing, Results The expression of ELM4-ALK fusion gene was detected and verified in the surgical specimen from a 36y female patient with T^NoM0 lung adenocarcinoma with a detection rate of 2.70%. The radical resection of upper lobe of the left lung was performed and XALKORI was given one month after the surgery. No metastasis was found after 6-months fol- low-up. Conclusion The detection rate for ELM4-ALK fusion gene is similar as reported in patients with lung adenocarcinoma, and the RT-PCR combined with sequencing is a sensitive and effective method for detection of EML4-ALK fusion gene in surgi- cal or biopsy specimens of patients with lung adenocarninoma.